{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:17:05Z","timestamp":1779207425027,"version":"3.51.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals","doi-asserted-by":"publisher","award":["VEO-001202"],"award-info":[{"award-number":["VEO-001202"]}],"id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40273-026-01599-z","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:43:58Z","timestamp":1772804638000},"page":"741-759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-999X","authenticated-orcid":false,"given":"Oscar","family":"Herrera-Restrepo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6065-8574","authenticated-orcid":false,"given":"Ginita","family":"Jutlla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3227-5928","authenticated-orcid":false,"given":"Jonathan","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4659-9309","authenticated-orcid":false,"given":"Justin","family":"Carrico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3862-8203","authenticated-orcid":false,"given":"Mei","family":"Grace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-3389","authenticated-orcid":false,"given":"Zeki","family":"Kocaata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2410-8951","authenticated-orcid":false,"given":"Diana E.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2860-1500","authenticated-orcid":false,"given":"Cindy","family":"Burman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0530-5340","authenticated-orcid":false,"given":"Anar","family":"Andani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-451X","authenticated-orcid":false,"given":"Hiral","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"1599_CR1","unstructured":"Mbaeyi S DJ, McNamara LA. Meningococcal disease. CDC-The Pink Book; 2021."},{"issue":"1","key":"1599_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13342-2","volume":"22","author":"J Shen","year":"2022","unstructured":"Shen J, Begum N, Ruiz-Garcia Y, Martinon-Torres F, Bekkat-Berkani R, Meszaros K. Range of invasive meningococcal disease sequelae and health economic application\u2014a systematic and clinical review. BMC Public Health. 2022;22(1):1078.","journal-title":"BMC Public Health"},{"issue":"1","key":"1599_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40121-021-00546-z","volume":"11","author":"J Shen","year":"2022","unstructured":"Shen J, Bou\u00e9e S, Aris E, Emery C, Beck EC. Long-term mortality and state financial support in invasive meningococcal disease\u2013real-world data analysis using the French National Claims Database (SNIIRAM). Infect Dis Ther. 2022;11(1):249\u201362.","journal-title":"Infect Dis Ther"},{"key":"1599_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-954","volume":"13","author":"LJ Clark","year":"2013","unstructured":"Clark LJ, Glennie L, Audrey S, Hickman M, Trotter CL. The health, social and educational needs of children who have survived meningitis and septicaemia: the parents\u2019 perspective. BMC Public Health. 2013;13:954.","journal-title":"BMC Public Health"},{"key":"1599_CR5","unstructured":"WHO. Meningitis: World Health Organization; 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/meningitis. Accessed 22 Nov 2023."},{"issue":"12","key":"1599_CR6","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1007\/s40121-024-01061-7","volume":"13","author":"O Herrera-Restrepo","year":"2024","unstructured":"Herrera-Restrepo O, Afroz N, Cabrera ES, Reaney M, Sowell FG, Kumar R, et al. Initial experiences with invasive meningococcal disease: insights from survivors and their caregivers. Infect Dis Ther. 2024;13(12):2581\u201395.","journal-title":"Infect Dis Ther"},{"issue":"12","key":"1599_CR7","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s40121-024-01060-8","volume":"13","author":"O Herrera-Restrepo","year":"2024","unstructured":"Herrera-Restrepo O, Afroz N, Cabrera ES, Reaney M, Sowell FG, Kumar R, et al. Life after invasive meningococcal disease: insights from survivors and their caregivers. Infect Dis Ther. 2024;13(12):2563\u201379.","journal-title":"Infect Dis Ther"},{"issue":"11","key":"1599_CR8","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s40121-024-01026-w","volume":"13","author":"GS Marshall","year":"2024","unstructured":"Marshall GS, McCormick ZL, Johns JS, Verduzco-Gutierrez M, Herrera-Restrepo O, Harrison LH. Understanding the sequelae of invasive meningococcal disease in the United States. Infect Dis Ther. 2024;13(11):2213\u201320.","journal-title":"Infect Dis Ther"},{"issue":"6","key":"1599_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40273-025-01477-0","volume":"43","author":"HA Shah","year":"2025","unstructured":"Shah HA, Jutlla G, Herrera-Restrepo O, Graham J, Grace M, Khan SA, et al. Market and non-market productivity losses associated with invasive meningococcal disease in the USA. Pharmacoeconomics. 2025;43(6):651\u201364.","journal-title":"Pharmacoeconomics"},{"key":"1599_CR10","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268823000328","volume":"151","author":"C de Pardo Santayana","year":"2023","unstructured":"Pardo de Santayana C, Tin Tin Htar M, Findlow J, Balmer P. Epidemiology of invasive meningococcal disease worldwide from 2010\u20132019: a literature review. Epidemiol Infect. 2023;151:e57.","journal-title":"Epidemiol Infect"},{"key":"1599_CR11","unstructured":"Centers for Disease Control and Prevention (CDC). Enhanced meningococcal disease surveillance report, 2022, 2024. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2022-508.pdf. Accessed 21 July 2025."},{"key":"1599_CR12","unstructured":"Centers for Disease Control and Prevention (CDC). Child and adolescent immunization schedule by age, 2025. https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/child-adolescent-age.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child-adolescent.html. Accessed 11 July 2025."},{"key":"1599_CR13","unstructured":"Centers for Disease Control and Prevention (CDC). Child immunization schedule notes, 2025. https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/child-adolescent-notes.html#note-mening. Accessed 29 July 2025."},{"issue":"9","key":"1599_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","volume":"69","author":"S Mbaeyi","year":"2020","unstructured":"Mbaeyi S, Bozio C, Duffy J, Rubin L, Hariri S, Stephens D, et al. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69(9):1\u201341.","journal-title":"MMWR Recomm Rep"},{"key":"1599_CR15","unstructured":"US Department of Health and Human Services. CDC acts on presidential memorandum to update childhood immunization schedule, 2026. https:\/\/www.hhs.gov\/press-room\/cdc-acts-presidential-memorandum-update-childhood-immunization-schedule.html. Accessed 7 Jan 2026."},{"key":"1599_CR16","unstructured":"Centers for Disease Control and Prevention (CDC). Childhood immunization schedule by recommendation group, 2026. https:\/\/www.hhs.gov\/childhood-immunization-schedule\/index.html. Accessed 7 Jan 2026."},{"key":"1599_CR17","unstructured":"Centers for Disease Control and Prevention (CDC). ACIP recommendations: October 25, 2023. https:\/\/www.cdc.gov\/acip\/downloads\/slides-2023-10-25-26\/04-Meningococcal-Collins-508.pdf. Accessed 29 Jul 2025."},{"key":"1599_CR18","unstructured":"Centers for Disease Control and Prevention (CDC). Meningococcal vaccine recommendations, 2025. https:\/\/www.cdc.gov\/meningococcal\/hcp\/vaccine-recommendations\/index.html. Accessed 29 Jul 2025."},{"issue":"33","key":"1599_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.15585\/mmwr.mm7333a1","volume":"73","author":"C Pingali","year":"2024","unstructured":"Pingali C, Yankey D, Chen M, Elam-Evans LD, Markowitz LE, DeSisto CL, et al. National vaccination coverage among adolescents aged 13\u201317\u00a0years\u2014National immunization survey-Teen, United States, 2023. MMWR Morb Mortal Wkly Rep. 2024;73(33):708\u201314.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"34","key":"1599_CR20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.15585\/mmwr.mm7234a3","volume":"72","author":"C Pingali","year":"2023","unstructured":"Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Valier MR, Fredua B, et al. Vaccination coverage among adolescents aged 13\u201317\u00a0years\u2014National immunization survey-Teen, United States, 2022. MMWR Morb Mortal Wkly Rep. 2023;72(34):912\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"1599_CR21","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jadohealth.2023.11.394","volume":"74","author":"O Herrera-Restrepo","year":"2024","unstructured":"Herrera-Restrepo O, Bunniran S, Mond T, Davenport E, Wang J, Sweeney C, et al. United States physicians\u2019 knowledge, attitudes, and practices regarding meningococcal vaccination for healthy adolescents and young adults. J Adolesc Health. 2024;74(6):1131\u20138.","journal-title":"J Adolesc Health"},{"issue":"1","key":"1599_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09181-8","volume":"20","author":"A Srivastava","year":"2020","unstructured":"Srivastava A, Dempsey A, Galitsky A, Fahimi M, Huang L. Parental awareness and utilization of meningococcal serogroup B vaccines in the United States. BMC Public Health. 2020;20(1):1109.","journal-title":"BMC Public Health"},{"issue":"1","key":"1599_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/03007995.2023.2285366","volume":"40","author":"O Herrera-Restrepo","year":"2024","unstructured":"Herrera-Restrepo O, Zhou Z, Krishnan A, Conley WJ, Oladele E, Multani JK, et al. Awareness, attitudes, and practices on meningococcal serogroup B vaccination in the United States among parents of older adolescents and among young adults. Curr Med Res Opin. 2024;40(1):125\u201340.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"1599_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/INF.0000000000003033","volume":"40","author":"J Fergie","year":"2021","unstructured":"Fergie J, Howard A, Huang L, Srivastava A. Implementation experience with meningococcal serogroup B vaccines in the United States: impact of a nonroutine recommendation. Pediatr Infect Dis J. 2021;40(3):269\u201375.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"1599_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.amepre.2020.09.013","volume":"60","author":"AJ Leidner","year":"2021","unstructured":"Leidner AJ, Tang Z, Tsai Y. Primary care use among commercially insured adolescents: evidence from the 2018 healthcare effectiveness data and information set. Am J Prev Med. 2021;60(3):411\u20134.","journal-title":"Am J Prev Med"},{"issue":"2s","key":"1599_CR26","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.acap.2018.01.002","volume":"18","author":"CM Rand","year":"2018","unstructured":"Rand CM, Goldstein NPN. Patterns of primary care physician visits for US adolescents in 2014: implications for vaccination. Acad Pediatr. 2018;18(2s):S72\u20138.","journal-title":"Acad Pediatr"},{"key":"1599_CR27","unstructured":"UNITY. Adolescent immunization: understanding challenges and framing solutions for healthcare providers, 2021. https:\/\/www.unity4teenvax.org\/resource\/adolescent-immunization-understanding-challenges-and-framing-solutions-for-healthcare-providers\/. Accessed 30 June 2025."},{"issue":"3","key":"1599_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s40273-024-01439-y","volume":"43","author":"HA Shah","year":"2024","unstructured":"Shah HA, Jutlla G, Herrera-Restrepo O, Graham J, Hicks KA, Carrico J, et al. Public health impact of introducing a pentavalent vaccine against invasive meningococcal disease in the United States. Pharmacoeconomics. 2024;43(3):311\u201329.","journal-title":"Pharmacoeconomics"},{"key":"1599_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127332","volume":"61","author":"X Dong","year":"2025","unstructured":"Dong X, Schillie SF, McNamara LA, Leidner AJ. Cost-effectiveness of pentavalent meningococcal (MenABCWY) vaccination among adolescents in the United States. Vaccine. 2025;61:127332.","journal-title":"Vaccine"},{"key":"1599_CR30","unstructured":"Centers for Disease Control and Prevention (CDC). Work Group Considerations regarding MenABCWY vaccine and discussion of potential risk groups for MenB vaccination, 2024. https:\/\/www.cdc.gov\/acip\/downloads\/slides-2024-06-26-28\/04-Mening-Schillie-508.pdf. Accessed 30 Jun 2025."},{"issue":"4","key":"1599_CR31","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1097\/INF.0000000000003455","volume":"41","author":"ER Packnett","year":"2022","unstructured":"Packnett ER, Zimmerman NM, Kim G, Novy P, Morgan LC, Chime N, et al. A real-world claims data analysis of meningococcal serogroup B vaccine series completion and potential missed opportunities in the United States. Pediatr Infect Dis J. 2022;41(4):e158\u201365.","journal-title":"Pediatr Infect Dis J"},{"key":"1599_CR32","unstructured":"PENMENVY PI. GSK. PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine). 2025. https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/en_US\/Prescribing_Information\/Penmenvy\/pdf\/PENMENVY.PDF. Accessed 06 May 2025."},{"key":"1599_CR33","unstructured":"PENBRAYA PI. Pfizer. PENBRAYA (Meningococcal Groups A, B, C, W, and Y Vaccine). 2024. https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=19937&format=pdf. Accessed 06 May 2025."},{"key":"1599_CR34","unstructured":"BEXSERO PI. GSK. BEXSERO (Meningococcal Group B Vaccine). 2024. https:\/\/www.fda.gov\/media\/90996\/download?attachment. Accessed 06 May 2025."},{"issue":"5","key":"1599_CR35","doi-asserted-by":"publisher","first-page":"P560","DOI":"10.1016\/S1473-3099(24)00667-4","volume":"25","author":"T Nolan","year":"2025","unstructured":"Nolan T, Bhusal C, Beran J, Bloch M, Cetin BS, Dinleyici EC, et al. Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial. Lancet Infect Dis. 2025;25(5):P560-573.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1599_CR36","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4161\/hv.7.4.14434","volume":"7","author":"KL Davis","year":"2011","unstructured":"Davis KL, Misurski D, Miller J, Karve S. Cost impact of complications in meningococcal disease: evidence from a United States managed care population. Hum Vaccin. 2011;7(4):458\u201365.","journal-title":"Hum Vaccin"},{"key":"1599_CR37","unstructured":"Ortega-Sanchez IR. The cost-effectiveness of a potential pentavalent meningococcal conjugate vaccine (Men ABCWY) versus the current Men ACWY and Men B vaccines for US adolescents, 2023. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2023-06-21-23\/02-Mening-Ortega-Sanchez-508.pdf. Accessed 01 July 2025."},{"issue":"5","key":"1599_CR38","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1542\/peds.2004-2514","volume":"115","author":"CW Shepard","year":"2005","unstructured":"Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Pediatrics. 2005;115(5):1220\u201332.","journal-title":"Pediatrics"},{"key":"1599_CR39","unstructured":"Ortega-Sanchez IR. Economics of potential pentavalent meningococcal conjugate vaccine (MenABCWY) versus the current MenACWY and MenB vaccines for US adolescents, 2023. https:\/\/www.cdc.gov\/acip\/downloads\/slides-2023-10-25-26\/03-Meningococcal-Ortega-Sanchez-508.pdf. Accessed 11 July 2025."},{"key":"1599_CR40","unstructured":"Ortega-Sanchez IR. The cost-effectiveness of a potential pentavalent meningococcal conjugate vaccine (Men ABCWY) versus the current Men ACWY and Men B vaccines for US adolescents, 2023. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2023-06-21-23\/02-Mening-Ortega-Sanchez-508.pdf. Accessed 30 June 2025."},{"issue":"10","key":"1599_CR41","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jama.2016.12195","volume":"316","author":"GD Sanders","year":"2016","unstructured":"Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093\u2013103.","journal-title":"JAMA"},{"key":"1599_CR42","unstructured":"US BLS. United States Bureau of Labor Statistics. Consumer price index for all urban consumers: medical care services in U.S. city average. 1 May 2025. https:\/\/fred.stlouisfed.org\/series\/CUSR0000SAM2. Accessed 30 May 2025."},{"key":"1599_CR43","unstructured":"US BEA. Federal Reserve Bank of St. Louis. Gross domestic product: implicit price deflator [GDPDEF]. 2025. https:\/\/fred.stlouisfed.org\/series\/GDPDEF. Accessed 30 May 2025."},{"issue":"8","key":"1599_CR44","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/cid\/cix993","volume":"66","author":"JR MacNeil","year":"2018","unstructured":"MacNeil JR, Blain AE, Wang X, Cohn AC. Current epidemiology and trends in meningococcal disease-United States, 1996-2015. Clin Infect Dis. 2018;66(8):1276\u201381.","journal-title":"Clin Infect Dis"},{"key":"1599_CR45","unstructured":"Centers for Medicare and Medicaid Services. Physician fee schedule lookup tool, 2023. https:\/\/www.cms.gov\/medicare\/payment\/fee-schedules\/physician\/lookup-tool. Accessed 29 July 2025."},{"key":"1599_CR46","unstructured":"Agency for Healthcare Research and Quality. Healthcare cost and utilization project, 2024. https:\/\/hcup-us.ahrq.gov\/. Accessed 30 May 2025."},{"key":"1599_CR47","unstructured":"Dong X, Leidner AJ, Schillie SF, Alexandra McNamara L. Economic analyses of GSK MenABCWY vaccinations among adolescents in the United States, 2024. https:\/\/www.cdc.gov\/acip\/downloads\/slides-2024-10-23-24\/02-Mening-Dong-508.pdf. Accessed 21 July 2025."},{"key":"1599_CR48","unstructured":"FDA. PENBRAYA highlights of prescribing information. https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=19937. Accessed 30 June 2025."},{"key":"1599_CR49","doi-asserted-by":"publisher","first-page":"509","DOI":"10.15585\/mmwr.mm6619a6","volume":"66","author":"M Patton","year":"2017","unstructured":"Patton M, Stephens D, Moore K, MacNeil J. Updated recommendations for use of MenB-FHbp serogroup B meningococcal vaccine\u2014Advisory Committee on Immunization Practices, 2016. MMWR Morb Mortal Wkly Rep. 2017;66:509\u201313.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1599_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-21953-8","volume":"25","author":"E Langevin","year":"2025","unstructured":"Langevin E, Robertson C, Galarza K, et al. Understanding the value of meningococcal vaccination for adolescents and young adults in the United States: insights from a steady-state modelling approach. BMC Public Health. 2025;25:1863.","journal-title":"BMC Public Health"},{"key":"1599_CR51","volume":"44","author":"A Shoukat","year":"2025","unstructured":"Shoukat A, Wells CR, Shin T, Potter-Schwartz L, Galvani AP, Moghadas SM. Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: a modelling study. Lancet Reg Health. 2025;44:101033.","journal-title":"Lancet Reg Health"},{"key":"1599_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127428","volume":"61","author":"J Shaw","year":"2025","unstructured":"Shaw J, Fergie JE, Conway JH, Marshall GS. Risks of removing the age 11\u201312-year meningococcal vaccine dose from the US immunization schedule. Vaccine. 2025;61:127428.","journal-title":"Vaccine"},{"issue":"11","key":"1599_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8111675","volume":"8","author":"SA Clark","year":"2020","unstructured":"Clark SA, Borrow R. Herd protection against meningococcal disease through vaccination. Microorganisms. 2020;8(11):1675.","journal-title":"Microorganisms"},{"issue":"5","key":"1599_CR54","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s40121-023-00793-2","volume":"12","author":"O Herrera-Restrepo","year":"2023","unstructured":"Herrera-Restrepo O, Kuang Y, D\u2019Angelo J, Bekkat-Berkani R, Clements DE, Uyei J. Determinants of meningococcal vaccination coverage and adherence: a targeted literature review supporting a 16-year-old healthcare visit. Infect Dis Ther. 2023;12(5):1265\u201382.","journal-title":"Infect Dis Ther"},{"key":"1599_CR55","first-page":"1","volume":"331","author":"JJ Ashman","year":"2019","unstructured":"Ashman JJ, Rui P, Okeyode T. Characteristics of office-based physician visits, 2016. NCHS Data Brief. 2019;331:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"1599_CR56","doi-asserted-by":"crossref","unstructured":"Herrera-Restrepo O, Multani JK, Zhou Z, Paltanwale Q, Olaiya T, Coutinho A, Shah R, Chen CC. Patterns of healthcare visits and vaccination among adolescents and young adults 16\u201323-years-old: a retrospective US claims database analysis. Curr Med Res Opin. 2025;41(8)1573\u20131587.","DOI":"10.1080\/03007995.2025.2556983"},{"issue":"10","key":"1599_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239926","volume":"15","author":"GS Chung","year":"2020","unstructured":"Chung GS, Hutton DW. Epidemiological impact and cost-effectiveness of universal meningitis b vaccination among college students prior to college entry. PLoS ONE. 2020;15(10):e0239926.","journal-title":"PLoS ONE"},{"issue":"2","key":"1599_CR58","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.amepre.2018.09.020","volume":"56","author":"IL Leeds","year":"2019","unstructured":"Leeds IL, Namasivayam V, Bamogo A, Sankhla P, Thayer WM. Cost effectiveness of meningococcal serogroup B vaccination in college-aged young adults. Am J Prev Med. 2019;56(2):196\u2013204.","journal-title":"Am J Prev Med"},{"key":"1599_CR59","unstructured":"Reber S, Smith E. College enrollment disparities: understanding the role of academic preparation: Center on Children and Families. The Brookings Institution, 2023. https:\/\/www.brookings.edu\/wp-content\/uploads\/2023\/02\/20230123_CCF_CollegeEnrollment_FINAL2.pdf. Accessed 29 July 2025."},{"issue":"26","key":"1599_CR60","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1016\/j.vaccine.2022.04.101","volume":"40","author":"G Sulis","year":"2022","unstructured":"Sulis G, Horn M, Borrow R, Basta NE. A comparison of national vaccination policies to prevent serogroup B meningococcal disease. Vaccine. 2022;40(26):3647\u201354.","journal-title":"Vaccine"},{"key":"1599_CR61","doi-asserted-by":"crossref","unstructured":"Shin T, Cristeau O, Upegui A, Neary MP, Robertson CA, Galarza K, et al. Modelling the epidemiological impact and cost-effectiveness of possible changes to the meningococcal vaccination schedule for adolescents and young adults in the United States. BMC Public Health. 2025;26(1):452.","DOI":"10.1186\/s12889-025-25726-1"},{"issue":"5","key":"1599_CR62","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2206433","volume":"388","author":"J Castilla","year":"2023","unstructured":"Castilla J, Garc\u00eda Cenoz M, Abad R, S\u00e1nchez-Cambronero L, Lorusso N, Izquierdo C, et al. Effectiveness of a meningococcal group B vaccine (4CMenB) in children. N Engl J Med. 2023;388(5):427\u201338.","journal-title":"N Engl J Med"},{"issue":"1","key":"1599_CR63","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s40121-020-00370-x","volume":"10","author":"A Biolchi","year":"2021","unstructured":"Biolchi A, Tomei S, Brunelli B, Giuliani M, Bambini S, Borrow R, et al. 4CMenB Immunization induces serum bactericidal antibodies against non-serogroup B meningococcal strains in adolescents. Infect Dis Ther. 2021;10(1):307\u201316.","journal-title":"Infect Dis Ther"},{"issue":"47","key":"1599_CR64","doi-asserted-by":"publisher","first-page":"7558","DOI":"10.1016\/j.vaccine.2020.08.007","volume":"38","author":"E Beck","year":"2020","unstructured":"Beck E, Klint J, Garcia S, Abbing V, Abitbol V, Akerborg O, et al. Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: an application to England. Vaccine. 2020;38(47):7558\u201368.","journal-title":"Vaccine"},{"issue":"1","key":"1599_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-21491-3","volume":"25","author":"K Schley","year":"2025","unstructured":"Schley K, Jan\u00dfen S, Sullivan SM, Tichy E, Findlow J. Public health impact and cost-effectiveness of introducing MenACWY vaccination strategies in Germany. BMC Public Health. 2025;25(1):1653.","journal-title":"BMC Public Health"},{"issue":"19","key":"1599_CR66","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/j.vaccine.2016.03.020","volume":"34","author":"H Lecocq","year":"2016","unstructured":"Lecocq H, du Parent Ch\u00e2telet I, Taha MK, L\u00e9vy-Bruhl D, Dervaux B. Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France. Vaccine. 2016;34(19):2240\u201350.","journal-title":"Vaccine"},{"issue":"1","key":"1599_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/524041","volume":"46","author":"IR Ortega-Sanchez","year":"2008","unstructured":"Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, et al. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Clin Infect Dis. 2008;46(1):1\u201313.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1599_CR68","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jval.2020.09.004","volume":"24","author":"EKJ Beck","year":"2021","unstructured":"Beck E, Klint J, Neine M, Garcia S, Meszaros K. Cost-effectiveness of 4CMenB infant vaccination in England: a comprehensive valuation considering the broad impact of serogroup B invasive meningococcal disease. Value Health. 2021;24(1):91\u2013104.","journal-title":"Value Health"},{"key":"1599_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5725","volume":"349","author":"H Christensen","year":"2014","unstructured":"Christensen H, Trotter CL, Hickman M, Edmunds WJ. Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study. BMJ. 2014;349:g5725.","journal-title":"BMJ"},{"key":"1599_CR70","doi-asserted-by":"crossref","unstructured":"Schley K, Presa J, Snow V, Cane A, Peyrani P, Farkouh R, et al. Cost-effectiveness of the pentavalent meningococcal vaccine (MenABCWY): a steady-state cohort modelling approach. Open Forum Infect Dis. 2023;10(Suppl 2):ofad500.987.","DOI":"10.1093\/ofid\/ofad500.987"},{"key":"1599_CR71","unstructured":"American Academy of Pediatrics. AAP immunization schedule, 2025. https:\/\/downloads.aap.org\/AAP\/PDF\/AAP-Immunization-Schedule.pdf. Accessed 21 Jan 2026."}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01599-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-026-01599-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01599-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:02:51Z","timestamp":1779206571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-026-01599-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1599"],"URL":"https:\/\/doi.org\/10.1007\/s40273-026-01599-z","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"OHR is employed by and holds financial equities in GSK; GJ received consulting fees from GSK; JG is employed by RTI Health Solutions, which was paid by GSK to conduct this study; JC is employed by and holds financial equities in GSK; MG is employed by RTI Health Solutions, which was paid by GSK to conduct this study; ZK is employed by and holds financial equities in GSK; DEC is employed by and held financial equities in GSK at the time of the study and is now employed by Johnson & Johnson; CB is employed by GSK and holds financial equities in GSK and Pfizer; AA is employed by and holds financial equities in GSK; and HS is employed by and holds financial equities in GSK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The data generated during and\/or analyzed during the current study are available within the paper and its Supplementary Information. Additional data may be requested from the corresponding author, as reasonable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Sharing Statement"}},{"value":"Substantial contributions to study conception and design: OHR, GJ, JG, ZK, DEC, CB, and HS; substantial contributions to analysis and interpretation of the data: OHR, GJ, JG, JC, MG, ZK, DEC, CB, AA, and HS; drafting the article or revising it critically for important intellectual content: OHR, GJ, JG, JC, MG, ZK, DEC, CB, AA, and HS; and final approval of the version of the article to be published: OHR, GJ, JG, JC, MG, ZK, DEC, CB, AA, and HS.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}